How Exercise Activates Autophagy to Protect Muscles, Brain, Heart and More

Autophagy — the conserved intracellular recycling system that degrades and repurposes damaged organelles and misfolded proteins — is increasingly recognized as a master regulator of healthspan. When autophagic flux is impaired, diseases ranging from Alzheimer's and Parkinson's to sarcopenia, cardiomyopathy, and type 2 diabetes accelerate. This review, from Chongqing Medical University, provides the most comprehensive synthesis to date of how physical exercise activates autophagy across multiple organ systems and what molecular machinery mediates those effects.

The authors identify three primary transduction routes linking exercise to autophagy induction. First, direct mechanical forces during muscle contraction activate mechanosensitive proteins including Piezo1 ion channels, integrins, and AMPK. Calcium influx through these channels activates CaMKKβ, which phosphorylates AMPK at Thr172, triggering the AMPK–FOXO3a and AMPK–ULK1 cascades to upregulate Beclin1 and initiate autophagic membrane formation. Importantly, the Piezo1 response is dose-dependent: mild-to-moderate mechanical stress enhances protective autophagy in nucleus pulposus cells, while excessive stress pathologically upregulates Piezo1 to suppress autophagy and worsen intervertebral disc degeneration. Second, exercise-induced blood flow generates shear stress on vascular endothelium, activating Ca²⁺ signaling and AMPK-dependent autophagy that clears arterial plaques and supports endothelial function. In atherosclerotic contexts, disturbed flow from plaques over-activates Piezo1, driving YAP nuclear translocation, inhibiting autophagy, and worsening endothelial dysfunction. Third, contracting skeletal muscle secretes myokines — including lactate, irisin, IGF-1, and VEGF — that regulate autophagy both locally and systemically. Lactate activates ERK1/2 via ROS, inhibits mTOR, and enhances skeletal muscle protein synthesis. Irisin promotes autophagy through the ATG12–ATG5–ATG16L complex, activates Wnt/β-catenin signaling for osteogenic differentiation, and drives AMPK–mTOR clearance of amyloid-beta in the brain.

The review devotes substantial attention to how exercise modality shapes the autophagic response. Aerobic exercise predominantly engages AMPK and mTOR pathways to support mitochondrial quality control and cellular homeostasis, including mitophagy — the selective clearance of dysfunctional mitochondria. Resistance and anaerobic training preferentially activates PI3K/Akt signaling, modulating FOXO3a and Beclin1 to drive muscle autophagy and repair after mechanical damage. Different muscle fiber types (Type I slow-twitch versus Type II fast-twitch) show distinct autophagic sensitivities, and individual factors including age, sex, and training status further modulate autophagic flux — an important caveat for translating findings across populations.

In pathological contexts examined by the review, exercise-induced autophagy confers striking benefits. In sarcopenia, AMPK–FOXO3a–Beclin1 signaling prevents muscle atrophy and restores protein turnover balance. In neurodegeneration, exercise-driven irisin and Piezo1-mediated CaMKII/AMPK/mTOR activation promotes autophagic clearance of amyloid-beta and tau aggregates. In cardiovascular disease, AMPK–ULK1 autophagy reduces cardiomyocyte apoptosis and alleviates endoplasmic reticulum stress after ischemic injury. In metabolic disease, autophagy-regulated lipophagy improves lipid homeostasis and insulin sensitivity. The review also highlights emerging links to cancer, where exercise-induced autophagy may suppress tumor initiation while improving immune surveillance.

A critical safety caveat runs throughout the review: excessive exercise — particularly chronic high-intensity training without adequate recovery — can pathologically over-activate autophagy, leading to muscle protein hypercatabolism and atrophy, or maladaptive cardiac remodeling. This dose-response complexity means that specific exercise prescriptions (intensity, duration, modality, recovery intervals) must be optimized rather than simply maximizing training volume. The authors call for future research to identify reliable autophagy biomarkers (beyond LC3-II and p62/SQSTM1) in accessible tissues, develop exercise protocols clinically validated for specific diseases, and explore combination strategies pairing exercise with pharmacological autophagy modulators such as rapamycin or metformin to amplify therapeutic outcomes.